{"id":43717,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/stock-purchase-agreement-ttr-technologies-inc-and-macrovision.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"stock-purchase-agreement-ttr-technologies-inc-and-macrovision","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/planning\/stock-purchase-agreement-ttr-technologies-inc-and-macrovision.html","title":{"rendered":"Stock Purchase Agreement &#8211; TTR Technologies Inc. and Macrovision Corp."},"content":{"rendered":"<pre>--------------------------------------------------------------------------------\n\n\n                            STOCK PURCHASE AGREEMENT\n\n                                     BETWEEN\n\n                             TTR TECHNOLOGIES, INC.\n\n                                       AND\n\n                             MACROVISION CORPORATION\n\n                          DATED AS OF JANUARY 10, 2000\n\n--------------------------------------------------------------------------------\n\n\n                                TABLE OF CONTENTS\n\n<\/pre>\n<table>\n<caption>\n                                                                                          PAGE<br \/>\n<s>                                                                                    <c><br \/>\n1.      PURCHASE AND SALE OF<br \/>\n        STOCK&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.1<\/p>\n<p>        1.1     Sale and Issuance of Common Stock&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.1<\/p>\n<p>        1.2     Closing&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;1<\/p>\n<p>2.      REPRESENTATIONS AND WARRANTIES OF THE COMPANY&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;1<\/p>\n<p>        2.1     Organization, Good Standing and Qualification&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.2<\/p>\n<p>        2.2     Capitalization and Voting Rights&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..2<\/p>\n<p>        2.3     Subsidiaries&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.3<\/p>\n<p>        2.4     Authorization&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;3<\/p>\n<p>        2.5     Valid Issuances of Common Stock&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;3<\/p>\n<p>        2.6     Compliance with Law and Charter Documents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..3<\/p>\n<p>        2.7     Compliance with Other Instruments, None Burdensome, Etc&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;4<\/p>\n<p>        2.8     Government Consent, Etc&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..5<\/p>\n<p>        2.9     Offering&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..5<\/p>\n<p>        2.10    Litigation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;5<\/p>\n<p>        2.11    Agreements; Action&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.5<\/p>\n<p>        2.12    Related Party Transactions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..6<\/p>\n<p>        2.13    Environmental and Safety Laws&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..6<\/p>\n<p>        2.14    Status of Proprietary Assets&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;7<\/p>\n<p>        2.15    Material Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;8<\/p>\n<p>        2.16    Disclosure&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;8<\/p>\n<p>        2.17    Registration Rights&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;9<\/p>\n<p>        2.18    Tax Status&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;9<\/p>\n<p>        2.19    Employees &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;9<\/p>\n<p>        2.20    Insurance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;10<\/p>\n<p>        2.21    Title to Property and Assets&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..10<\/p>\n<p>        2.22    Financial Statements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.10<\/p>\n<p>        2.23    SEC Documents, Financial Statements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.11<\/p>\n<p>        2.24    No Integrated Offering&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..11<\/p>\n<p>        2.25    Year 2000&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;12<\/p>\n<p><\/c><\/s><\/caption>\n<\/table>\n<p>                                        i<\/p>\n<p>                                TABLE OF CONTENTS<br \/>\n                                   (CONTINUED)<\/p>\n<table>\n<caption>\n<p>                                                                                          PAGE<br \/>\n<s>                                                                                    <c><br \/>\n3.      REPRESENTATIONS AND WARRANTIES OF THE INVESTOR&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.12<\/p>\n<p>        3.1     Authorization&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..12<\/p>\n<p>        3.2     Purchase Entirely for Own Account&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;12<\/p>\n<p>        3.3     Disclosure of Information&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..12<\/p>\n<p>        3.4     Investment Experience&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;13<\/p>\n<p>        3.5     Accredited Investor&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..13<\/p>\n<p>        3.6     Restricted Securities&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;13<\/p>\n<p>        3.7     Legends&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..13<\/p>\n<p>4.      COVENANTS AND AGREEMENTS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..14<\/p>\n<p>        4.1     Ordinary Course of Business and Notice of Adverse Changes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;14<\/p>\n<p>        4.2     Access to Properties and Records&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.14<\/p>\n<p>        4.3     Exclusive Negotiations&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..14<\/p>\n<p>        4.4     Right of First Refusal&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..15<\/p>\n<p>        4.5     Preemptive Right of Investor&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..16<\/p>\n<p>        4.6     Certain Employment Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.17<\/p>\n<p>        4.7     Board Observer&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.17<\/p>\n<p>        4.8     Registration of Shares&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..18<\/p>\n<p>        4.9     Form D; Blue Sky Laws&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;18<\/p>\n<p>        4.10    Reporting Status; Eligibility to Use Form S-1&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;18<\/p>\n<p>5.      CONDITIONS OF INVESTOR&#8217;S OBLIGATIONS AT CLOSING&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;19<\/p>\n<p>        5.1     Execution of Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..19<\/p>\n<p>        5.2     Shares Certificate&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;19<\/p>\n<p>        5.3     Representatives, Warranties, Covenants&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.19<\/p>\n<p>        5.4     Litigation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..20<\/p>\n<p>        5.5     Stock Listing&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..20<\/p>\n<p>        5.6     Opinion&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..20<\/p>\n<p>        5.7     Alliance Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;20<\/p>\n<p>        5.8     Financial Statements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.20<\/p>\n<p>        5.9     Accounting for Investment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..20<\/p>\n<p><\/c><\/s><\/caption>\n<\/table>\n<p>                                       ii<\/p>\n<p>                                TABLE OF CONTENTS<br \/>\n                                   (CONTINUED)<\/p>\n<table>\n<caption>\n<p>                                                                                          PAGE<br \/>\n<s>                                                                                    <c><br \/>\n6.      CONDITIONS OF THE COMPANY&#8217;S OBLIGATIONS AT CLOSING&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;20<\/p>\n<p>        6.1     Execution of Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..21<\/p>\n<p>        6.2     Purchase Price&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.21<\/p>\n<p>        6.3     Representations, Warranties, Covenants&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.21<\/p>\n<p>        6.4     Legal Impediment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..21<\/p>\n<p>        6.5     Alliance Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;21<\/p>\n<p>7.      DEFINITIONS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;21<\/p>\n<p>8.      MISCELLANEOUS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.22<\/p>\n<p>        8.1     Survival of Warranties&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..22<\/p>\n<p>        8.2     Successor and Assigns&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;23<\/p>\n<p>        8.3     Governing Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..23<\/p>\n<p>        8.4     Counterparts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;23<\/p>\n<p>        8.5     Titles and Subtitles&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.23<\/p>\n<p>        8.6     Notices&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..23<\/p>\n<p>        8.7     Finder&#8217;s Fee&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;24<\/p>\n<p>        8.8     Expenses&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.24<\/p>\n<p>        8.9     Amendments and Waivers&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..25<\/p>\n<p>        8.10    Severability&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;25<\/p>\n<p>        8.11    Entire Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..25<\/p>\n<p><\/c><\/s><\/caption>\n<\/table>\n<p>                                      iii<\/p>\n<p>        THIS STOCK PURCHASE AGREEMENT, effective as of January 10, 2000, is by<br \/>\nand between TTR TECHNOLOGIES, INC., a Delaware corporation (the &#8220;Company&#8221;), and<br \/>\nMACROVISION CORPORATION, a Delaware corporation (the &#8220;Investor&#8221;).<\/p>\n<p>        THE PARTIES HEREBY AGREE AS FOLLOWS:<\/p>\n<p>        1.      PURCHASE AND SALE OF STOCK<\/p>\n<p>                1.1     SALE AND ISSUANCE OF COMMON STOCK. Subject to the terms<br \/>\nand conditions of this Agreement, the Investor agrees to purchase at the Closing<br \/>\nand the Company agrees to sell and issue to the Investor at the Closing, one<br \/>\nmillion, eight hundred eighty thousand, nine hundred thirty-seven shares<br \/>\n(1,880,937) of the Company&#8217;s Common Stock $0.001 par value (the &#8220;Shares&#8221;). The<br \/>\npurchase price for the Shares (subject to adjustment as provided in section 4.8<br \/>\nhereof) shall be Two Dollars and Thirteen Cents ($2.1266) per Share, or an<br \/>\naggregate purchase price of Four Million Dollars ($4,000,000) (the &#8220;Purchase<br \/>\nPrice&#8221;), which purchase price assumes that such Shares will be registered under<br \/>\nthe Securities Act within 90 days of the Closing and will be freely tradable as<br \/>\nof that time by Investor, without regard to exemptions under the Securities Act.<br \/>\nThe per share Purchase Price of each Share shall be determined by dividing the<br \/>\nnumber of shares of Common Stock outstanding immediately prior to the Closing,<br \/>\non a fully diluted basis, into $31 million. The number of Shares of Common Stock<br \/>\nto be issued to Investor shall be determined by dividing the per share Purchase<br \/>\nPrice, determined in the preceding sentence, into the aggregate $4 million<br \/>\nPurchase Price.<\/p>\n<p>                1.2     CLOSING. The purchase and sale of the Common Stock shall<br \/>\ntake place at the offices of Manatt, Phelps &amp; Phillips LLP, 3030 Hansen Way,<br \/>\nSuite 100, Palo Alto, California (or such other location as the Investor may<br \/>\ndesignate and the Company consents thereto), at 10:00 A.M. on January 12, 2000,<br \/>\nor such other time and date as the Investor determines that all of the<br \/>\nconditions to the obligation of Investor, set forth in Section 5 hereof, have<br \/>\nbeen or will be satisfied (the &#8220;Closing&#8221;). At the Closing, the Company shall<br \/>\ndeliver to the Investor a certificate representing the Shares against receipt by<br \/>\nthe Company from the Investor of a wire transfer in the amount of the Purchase<br \/>\nPrice.<\/p>\n<p>                                       1<\/p>\n<p>        2.      REPRESENTATIONS AND WARRANTIES OF THE COMPANY.<\/p>\n<p>        The Company hereby represents and warrants to the Investor, except as<br \/>\nset forth on a Schedule of Exceptions attached as SCHEDULE A hereto (the<br \/>\n&#8220;Schedule of Exceptions&#8221;), specifically identifying the relevant subparagraph<br \/>\nhereof, which exceptions shall be deemed to be a part of the representations and<br \/>\nwarranties as if made hereunder (provided that such Schedule of Exceptions may,<br \/>\nat the discretion of the Company, be amended from time to time as necessary<br \/>\nuntil Closing, so long as such amendments do not reflect any material change in<br \/>\nthe disclosure), the following:<\/p>\n<p>                2.1     ORGANIZATION, GOOD STANDING AND QUALIFICATION. The<br \/>\nCompany is a corporation duly organized, validly existing and in good standing<br \/>\nunder the laws of the State of Delaware and has all requisite corporate power<br \/>\nand authority to carry on its business as now conducted and as proposed to be<br \/>\nconducted. The Company is duly qualified to transact business and is in good<br \/>\nstanding in each jurisdiction in which the failure so to qualify would have a<br \/>\nMaterial Adverse Effect on its business or properties.<\/p>\n<p>                2.2     CAPITALIZATION AND VOTING RIGHTS. Immediately prior to<br \/>\nthe Closing, the authorized capital of the Company will consist of:<\/p>\n<p>                        (i)     CAPITAL STOCK. 25,000,000 shares of common stock<br \/>\n(&#8220;Common Stock&#8221;), of which 10,602,866 are issued and outstanding and 5,000,000<br \/>\nshares of preferred stock, none of which are issued and outstanding. The Company<br \/>\nhas reserved an aggregate 1,500,000 shares of Common Stock under its 1996<br \/>\nemployee stock option plan for purposes of (i) future grants of stock options to<br \/>\nemployees, consultants and directors (hereinafter, the &#8220;ESOP&#8221;), and (ii)<br \/>\nissuance to holders of previously granted stock options upon exercise of such<br \/>\noptions. Additionally, the company has reserved an additional 25,000 shares of<br \/>\ncommon stock under its non-executive directors option plan for issuance to its<br \/>\nnon-employee directors. There is no other class or series of stock authorized.<\/p>\n<p>                        (ii)    WARRANTS AND OPTIONS. The Company has warrants<br \/>\nand options exercisable and outstanding to purchase up to an aggregate of<br \/>\n3,224,911 shares of Common Stock, except for 749,400 ESOPS currently exercisable<br \/>\nand outstanding.<\/p>\n<p>                                       2<\/p>\n<p>                        (iii)   OTHER AGREEMENTS. Except as set forth in this<br \/>\nAgreement and in the Schedule of Exceptions, there are no outstanding options,<br \/>\nwarrants, convertible securities, rights (including conversion, right of first<br \/>\nrefusal or any preemptive rights) or agreements for the purchase or acquisition<br \/>\nfrom the Company of any shares of its capital stock or any future issuance of<br \/>\nsecurities by the Company.<\/p>\n<p>                        (iv)    VOTING AGREEMENTS. Except as set forth in this<br \/>\nAgreement, the Company has no agreement, obligation or commitment with respect<br \/>\nto the election of any individual or individuals to the Board, and to the best<br \/>\nof the Company&#8217;s knowledge, there is no voting agreement or other arrangement<br \/>\namong its shareholders with respect to the election of any individual or<br \/>\nindividuals to the Board.<\/p>\n<p>                        (v)     COMMON STOCK OUTSTANDING. The total number of<br \/>\nshares of the Company&#8217;s Common Stock outstanding on a fully diluted basis,<br \/>\nimmediately prior to the Closing, is 14,577,177 shares.<\/p>\n<p>                2.3     SUBSIDIARIES. Except for TTR Technologies, Ltd., the<br \/>\nCompany&#8217;s wholly-owned Israeli subsidiary with offices in Kfar-Saba, Israel, the<br \/>\nCompany does not own or control, directly or indirectly, any other corporation,<br \/>\nassociation, or other business entity.<\/p>\n<p>                2.4     AUTHORIZATION. All corporate action on the part of the<br \/>\nCompany, its directors and shareholders necessary for the authorization,<br \/>\nexecution and delivery of this Agreement, the performance of all obligations of<br \/>\nthe Company hereunder and the authorization, issuance and delivery of the Common<br \/>\nStock being sold hereunder has been taken or will be taken prior to the Closing,<br \/>\nand this Agreement, upon due execution and delivery, constitutes a valid and<br \/>\nbinding obligation of the Company, enforceable in accordance with its terms,<br \/>\nexcept (i) as limited by applicable bankruptcy, insolvency, reorganization,<br \/>\nmoratorium, and other laws of general application affecting enforcement of<br \/>\ncreditors&#8217; rights generally, and (ii) as limited by laws relating to the<br \/>\navailability of specific performance, injunctive relief, or other equitable<br \/>\nremedies.<\/p>\n<p>                2.5     VALID ISSUANCES OF COMMON STOCK. The Shares which are<br \/>\nbeing purchased by the Investor hereunder, when issued, sold and delivered in<br \/>\naccordance with the <\/p>\n<p>                                       3<\/p>\n<p>terms hereof for the consideration expressed herein, will be duly and validly<br \/>\nissued, fully paid and nonassessable, and the Investor shall have good and<br \/>\nmarketable title to such Shares, free and clear of any liens, pledges,<br \/>\nencumbrances, taxes, charges or restrictions of any kind (other than those<br \/>\ncreated by or through the Investor).<\/p>\n<p>                2.6     COMPLIANCE WITH LAW AND CHARTER DOCUMENTS. The Company<br \/>\nis not in violation of, or default under, any provisions of its Certificate of<br \/>\nIncorporation or Bylaws, both as currently in effect. To its knowledge, the<br \/>\nCompany is in compliance in all material respects with all applicable laws,<br \/>\nrules, regulations, judgments, decrees and governmental orders, except for such<br \/>\nnon-compliance that would not have a Material Adverse Effect on the properties,<br \/>\nfinancial condition, operations, prospects or business of the Company. The<br \/>\nCompany has received no notice of any violation of such laws, rules,<br \/>\nregulations, judgments, decrees or orders which has not been remedied prior to<br \/>\nthe date hereof or which would have a Material Adverse Effect on the Company.<br \/>\nThe execution, delivery and performance of the Agreement and the consummation of<br \/>\nthe transactions contemplated thereby will not result in any such violation or<br \/>\ndefault, or be in conflict with or constitute, with or without the passage of<br \/>\ntime or the giving of notice or both, either a default under the Company&#8217;s<br \/>\nCertificate of Incorporation or Bylaws, both as currently in effect, or an event<br \/>\nwhich results in the creation of any material lien, charge or encumbrance upon<br \/>\nthe capital stock or any asset of the Company, or a default under any Material<br \/>\nAgreement or contract by the Company, or a violation of any laws, rules,<br \/>\nregulations, judgments, decrees or orders. All material licenses, permits,<br \/>\napprovals, registrations, qualifications, certificates and other authorizations<br \/>\nnecessary for the conduct of the Company&#8217;s business as presently conducted (the<br \/>\n&#8220;Licenses&#8221;) have been duly obtained and are in full force and effect, and there<br \/>\nare no proceedings pending or threatened which may result in the revocation,<br \/>\ncancellation, suspension or any material adverse modification of any of such<br \/>\nLicenses, except for Licenses that, individually or in the aggregate, the<br \/>\nCompany need not hold or possess in order to avoid a Material Adverse Effect on<br \/>\nthe Company&#8217;s assets, properties, financial condition, operating results or<br \/>\nbusiness. The Company believes it can obtain, without undue burden or expense,<br \/>\nany similar authority for the conduct of its business in the future as presently<br \/>\nconducted and proposed to be conducted.<\/p>\n<p>                                       4<\/p>\n<p>                2.7     COMPLIANCE WITH OTHER INSTRUMENTS, NONE BURDENSOME, ETC.<br \/>\nThe execution, delivery and performance of and compliance with this Agreement<br \/>\nand the issuance and sale of the Shares will not result in nor constitute any<br \/>\nbreach, default or violation of (i) any agreement, contract, lease, license,<br \/>\ninstrument or commitment (oral or written) to which the Company is a party or is<br \/>\nbound and which involves payment by the Company or any of its subsidiaries in<br \/>\nexcess of $250,000 or which is otherwise material to the business, properties,<br \/>\nfinancial condition or results of operation of the Company or its subsidiaries<br \/>\n(a &#8220;Material Agreement&#8221;) or (ii) any law, rule, regulation, statute or order<br \/>\napplicable to the Company, any of its subsidiaries or their respective<br \/>\nproperties, nor result in the creation of any mortgage, pledge, lien,<br \/>\nencumbrance or charge upon any of the properties or assets of the Company or its<br \/>\nsubsidiaries.<\/p>\n<p>                2.8     GOVERNMENT CONSENT, ETC. No consent, approval, order or<br \/>\nauthorization of, or designation, registration, declaration or filing with, any<br \/>\nfederal, state, local or provincial or other governmental authority on the part<br \/>\nof the Company is required in connection with the valid execution and delivery<br \/>\nof this Agreement or the consummation of the transactions contemplated herein,<br \/>\nincluding the offer, sale or issuance of the Shares to the Investor.<\/p>\n<p>                2.9     OFFERING. In reliance on the representations and<br \/>\nwarranties of Investor in Section 3, hereof, the offer, sale and issuance of the<br \/>\nShares will not, to the best knowledge of the Company, result in a violation of<br \/>\nthe requirements of Section 5 of the Securities Act or the qualification or<br \/>\nregistration requirements of the California or other applicable blue sky laws or<br \/>\nforeign laws as such laws exist on the date hereof.<\/p>\n<p>                2.10    LITIGATION. There is no action, suit, proceeding or<br \/>\ninvestigation pending or currently threatened against the Company which<br \/>\nquestions the validity of this Agreement or the consummation of the transactions<br \/>\ncontemplated hereby or which might result, either individually or in the<br \/>\naggregate, in any Material Adverse Effects on the assets, financial condition,<br \/>\noperations or business of the Company, financially or otherwise, or any change<br \/>\nin the current equity ownership of the Company. The Company is not a party or<br \/>\nsubject to the provisions of any order, writ, injunction, judgment or decree of<br \/>\nany court or government agency or instrumentality. <\/p>\n<p>                                       5<\/p>\n<p>There is no action, suit, proceeding or investigation by the Company currently<br \/>\npending or which the Company currently intends to initiate.<\/p>\n<p>                2.11    AGREEMENTS; ACTION.<\/p>\n<p>                        (i)     Since November 30, 1999, the Company has not (i)<br \/>\ndeclared or paid any dividends, or authorized or made any distribution upon or<br \/>\nwith respect to any class or series of its capital stock, (ii) incurred any<br \/>\nindebtedness for money borrowed or any other liabilities in excess of $250,000,<br \/>\n(iii) made any loans or advances to any person, other than ordinary advances for<br \/>\ntravel expenses, or (iv) sold, exchanged or otherwise disposed of any of its<br \/>\nassets or rights, other than the sale of its inventory in the ordinary course of<br \/>\nbusiness.<\/p>\n<p>                        (ii)    Except as set forth in the Schedule of<br \/>\nExceptions, the Company has not engaged since November 24, 1999 in any<br \/>\ndiscussion (i) with any representative of any corporation or corporations<br \/>\nregarding the consolidation or merger of the Company with or into any such<br \/>\ncorporation or corporations, (ii) with any corporation, partnership, association<br \/>\nor other business entity or any individual regarding the sale, conveyance or<br \/>\ndisposition of all or substantially all of the assets of the Company or a<br \/>\ntransaction or series of related transactions in which more than fifty (50%) of<br \/>\nthe voting ownership of the Company is disposed of, or (iii) regarding any other<br \/>\nform of acquisition, liquidation, dissolution or winding up of the Company.<\/p>\n<p>                2.12    RELATED PARTY TRANSACTIONS.<\/p>\n<p>                        (i)     No employee, officer or director of the Company<br \/>\nor member of his or her immediate family is indebted to the Company, nor is the<br \/>\nCompany indebted (or committed to make loans or extend or guarantee credit) to<br \/>\nany of them.<\/p>\n<p>                        (ii)    To the best of the Company&#8217;s knowledge, no<br \/>\nemployee or officer has any direct or indirect ownership interest in any firm or<br \/>\ncorporation with which the Company is affiliated or with which the Company has a<br \/>\nbusiness relationship, or any firm or corporation that competes with the<br \/>\nCompany, except that employees or officers of the Company and members of their<br \/>\nimmediate families may own stock in publicly traded companies that may compete<br \/>\nwith the Company. Prior to the Closing, no officer, director or major<br \/>\nshareholder or member of the <\/p>\n<p>                                       6<\/p>\n<p>immediate family of any officer, director or major shareholder of the Company<br \/>\nhas a direct or indirect financial interest in any material contract with the<br \/>\nCompany.<\/p>\n<p>                2.13    ENVIRONMENTAL AND SAFETY LAWS. To the best of its<br \/>\nknowledge, the Company is not in violation of any applicable statute, law, or<br \/>\nregulation relating to the environment or occupational health and safety, and to<br \/>\nthe best of its knowledge, no material expenditures are or will be required to<br \/>\ncomply with any such existing statute, law, or regulation.<\/p>\n<p>                2.14    STATUS OF PROPRIETARY ASSETS.<\/p>\n<p>                        (i)     OWNERSHIP. The Company owns, is licensed to use<br \/>\nor otherwise has the right to use all patents, trademarks, service marks, trade<br \/>\nnames, copyrights and trade secrets that are material or necessary for the<br \/>\noperation of its business as now conducted (the &#8220;Proprietary Assets&#8221;). The<br \/>\nCompany has not received within the past 36 months preceding the date first set<br \/>\nout above any communications alleging that the Company has violated or, by<br \/>\nconducting its business, would violate any of the patents, trademarks, service<br \/>\nmarks, trade names, copyrights, trade secrets or other proprietary rights or<br \/>\nprocesses of any other person or entity. The Company has not granted any license<br \/>\nor option or entered into any agreement of any kind with respect to the use of<br \/>\nthe Proprietary Assets owned by it, other than licenses to and sales of its<br \/>\nproducts and services made in the ordinary course of its business.<\/p>\n<p>                        (ii)    LICENSES; OTHER AGREEMENTS. The Company is not<br \/>\nbound by or a party to any option, license or agreement with respect to any<br \/>\ntechnology owned by any third party other than shrink-wrap licenses entered into<br \/>\nin the ordinary course of business except as set forth on the Schedule of<br \/>\nExceptions. The Company is not obligated to pay any royalties or other payments<br \/>\nto another person or entity with respect to the marketing, sale, distribution,<br \/>\nmanufacture, license or use of any Proprietary Asset or any other property or<br \/>\nrights, except as set forth in the Schedule of Exceptions.<\/p>\n<p>                        (iii)   NO BREACH BY EMPLOYEES. To the best of the<br \/>\nCompany&#8217;s knowledge, no employee of the Company is subject to any judgment,<br \/>\ndecree or order of any court or administrative agency, or any other restriction<br \/>\nthat would materially interfere with the use of his or her best efforts to carry<br \/>\nout his or her duties for the Company or that would conflict <\/p>\n<p>                                       7<\/p>\n<p>with the Company&#8217;s business as currently conducted. The Company has received no<br \/>\nwritten notice from any former employer that any employee of the Company has<br \/>\nprior obligations to a former employer that would interfere or conflict with<br \/>\nsuch employee&#8217;s ability to perform his or her intended services for the Company.<br \/>\nTo the best of the Company&#8217;s knowledge and belief, no employee or advisor of the<br \/>\nCompany is or is now expected to be in violation of any term of any employment<br \/>\ncontract, patent disclosure agreement, proprietary information and inventions<br \/>\nagreement or any other contract or agreement or any restrictive covenant or any<br \/>\nother common law obligation to a former employer relating to the right of any<br \/>\nsuch employee to be employed by the Company because of the nature of the<br \/>\nbusiness conducted by the Company or to the use of trade secrets or proprietary<br \/>\ninformation of others, and the employment of the Company&#8217;s employees does not<br \/>\nsubject the Company to any liability, except where such liability would not have<br \/>\na material adverse effect. There is neither pending nor, to the Company&#8217;s<br \/>\nknowledge and belief, threatened any actions, suits, proceedings or claims, or<br \/>\nto its knowledge any basis therefor or threat thereof with respect to any<br \/>\ncontract, agreement, covenant or obligation referred to in the preceding<br \/>\nsentence.<\/p>\n<p>                        (iv)    NO INFRINGEMENT. Within the 36 months preceding<br \/>\nthe date first set out above, no claims with respect to the Proprietary Assets<br \/>\nhave been communicated to the Company: (A) to the effect that the manufacture,<br \/>\nsale, license or use of any Proprietary Asset as now used or offered or proposed<br \/>\nfor use or sale by the Company infringes any copyright, patent, trade secret or<br \/>\nother intellectual property right of a third party, or (B) challenging the<br \/>\nownership or validity of any of the Company&#8217;s rights to or interest in such<br \/>\nProprietary Assets. The Company has received no notice to the effect that any<br \/>\npatents or registered trademarks, service marks or registered copyright, held by<br \/>\nthe Company are invalid or not subsisting except for failures to be valid and<br \/>\nsubsisting that would not reasonably be expected to have, individually or in the<br \/>\naggregate, a Material Adverse Effect on the Company. To the best of the<br \/>\nCompany&#8217;s knowledge, there has been no material unauthorized use, infringement<br \/>\nor misappropriation of any of the Proprietary Assets by any third party,<br \/>\nincluding any employee or former employee of the Company.<\/p>\n<p>                2.15    MATERIAL AGREEMENTS. The Company has not breached in any<br \/>\nmaterial respect any term or condition of (A) any Material Agreement or (B) any<br \/>\nother agreement, <\/p>\n<p>                                       8<\/p>\n<p>contract, lease, license, instrument or commitment (oral or written) that,<br \/>\nindividually or in the aggregate, would have a Material Adverse Effect on the<br \/>\nproperties, financial condition, operating results, prospects or business of the<br \/>\nCompany. The Company is not a party to any agreement that restricts in any<br \/>\nmaterial respect its ability to market, sell or license any of its products or<br \/>\nservices (whether by territorial restriction or otherwise).<\/p>\n<p>                2.16    DISCLOSURE. The Company has fully provided the Investor<br \/>\nwith all information which the Investor has requested for deciding whether to<br \/>\npurchase the Shares and the Company is not aware of any material information<br \/>\nwhich it has not provided to the Investor and which the Company believes is<br \/>\nreasonably necessary to enable the Investor to decide whether to enter into the<br \/>\ntransaction contemplated by this Agreement. Neither this Agreement nor any other<br \/>\ncertificate made or delivered in connection with this Agreement and the<br \/>\ntransactions contemplated hereby contains any untrue statement of a material<br \/>\nfact or omits to state a material fact necessary not to make the statements<br \/>\nherein or therein misleading.<\/p>\n<p>                2.17    REGISTRATION RIGHTS. The Company has not granted or<br \/>\nagreed to grant to any person or entity any rights (including piggyback<br \/>\nregistration rights) to have any securities of the Company registered with the<br \/>\nUS Securities and Exchange Commission (&#8220;SEC&#8221;) or any other governmental<br \/>\nauthority.<\/p>\n<p>                2.18    TAX STATUS. The Company has made or filed all federal,<br \/>\nstate and foreign income and all other tax returns, reports and declarations<br \/>\nrequired by any jurisdiction to which it is subject and has paid all taxes and<br \/>\nother governmental assessments and charges that are shown to be due on such<br \/>\nreturns, reports and declarations or otherwise due, except those being contested<br \/>\nin good faith, and has set aside on its books provisions reasonably adequate for<br \/>\nthe payment of all taxes for periods subsequent to the periods to which such<br \/>\nreturns, reports or declarations apply. To the knowledge of the Company, there<br \/>\nare no unpaid taxes in any material amount claimed to be due by the taxing<br \/>\nauthority of any jurisdiction, and the officers of the Company know of no basis<br \/>\nfor any such claim. The Company has not executed a waiver with respect to the<br \/>\nstatute of limitations relating to the assessment or collection of any foreign,<br \/>\nfederal, state or local tax. None of the Company&#8217;s tax returns is presently<br \/>\nbeing audited by any taxing authority.<\/p>\n<p>                                       9<\/p>\n<p>                2.19    EMPLOYEES.<\/p>\n<p>                        (i)     EMPLOYEE BENEFIT PLANS. The Company does not<br \/>\nhave any Employee Benefit Plan as defined in the Employee Retirement Income<br \/>\nSecurity Act of 1974.<\/p>\n<p>                        (ii)    LABOR AGREEMENTS AND ACTIONS. The Company is not<br \/>\nbound by or subject to (and none of its assets or properties is bound by or<br \/>\nsubject to) any written or oral, express or implied, contract, commitment or<br \/>\narrangement with any labor union, and no labor union has requested or to the<br \/>\nknowledge of the Company, has sought to represent any of the employees,<br \/>\nrepresentatives or agents of the Company. There is no strike or other labor<br \/>\ndispute involving the Company pending, or to the knowledge of the Company<br \/>\nthreatened, which could have a Material Adverse Effect on the assets,<br \/>\nproperties, financial condition, operation or business of the Company, nor is<br \/>\nthe Company aware of any labor organization activity involving its employees.<br \/>\nThe employment of each officer and employee of the Company is terminable at the<br \/>\nwill of the Company upon the giving of notice and the payment of specified<br \/>\namounts. Company has complied in all material respects with all applicable state<br \/>\nand federal equal employment opportunity laws and with other laws related to<br \/>\nemployment.<\/p>\n<p>                        (iii)   CONFIDENTIAL INFORMATION AND INVENTION<br \/>\nASSIGNMENT AGREEMENTS. Each management and technology employee, consultant and<br \/>\nofficer of the Company has executed an agreement with the Company regarding<br \/>\nconfidentiality and proprietary information. The Company is not aware that any<br \/>\nof its employees or consultants is in violation thereof, and the Company will<br \/>\nuse its best efforts to prevent any such violation.<\/p>\n<p>                2.20    INSURANCE. The Company maintains and keeps in force with<br \/>\ngood and responsible insurance companies fire, public liability, property damage<br \/>\nand other insurance, of the kinds and in amounts as are usual and customary in<br \/>\nthe type of business conducted by the Company.<\/p>\n<p>                2.21    TITLE TO PROPERTY AND ASSETS. The Company owns and has<br \/>\nvalid title to its property and assets free and clear of all mortgages, liens,<br \/>\nloans and encumbrances, except such encumbrances and liens which arise in the<br \/>\nordinary course of business and do not materially impair the Company&#8217;s ownership<br \/>\nor use of such property or assets or which would not, in the aggregate, have a<br \/>\nMaterial Adverse Effect. With respect to the property and assets it leases, the<br \/>\nCompany is in compliance with such leases and, to the best of its knowledge,<br \/>\nholds a valid <\/p>\n<p>                                       10<\/p>\n<p>leasehold interest free of any liens, claims or encumbrances. The Company does<br \/>\nnot own any real property.<\/p>\n<p>                2.22    FINANCIAL STATEMENTS. The Company shall deliver to<br \/>\nInvestor, on or before January 10, 2000, the Company&#8217;s annual financial<br \/>\nstatements (balance sheet and statement of earnings, statement of shareholders&#8217;<br \/>\nequity and statement of cash flows) dated as of December 31, 1998 and interim<br \/>\nfinancial statements for the eleven months of operations ended November 30, 1999<br \/>\n(the &#8220;Financial Statements&#8221;), in each case, such Financial Statements shall be<br \/>\nprepared in accordance with United States generally accepted accounting<br \/>\nprinciples (&#8220;GAAP&#8221;), shall include all footnotes in accordance with GAAP, and<br \/>\nshall be audited by the Israeli office or affiliate of a &#8220;Big 5&#8221; public<br \/>\naccounting firm (i.e., Deloitte and Touche, KPMG Peat Marwick, Price Waterhouse<br \/>\nCoopers, Arthur Anderson or Ernst and Young). The Financial Statements when<br \/>\ndelivered, will fairly present the financial condition and operations of the<br \/>\nCompany as of the dates, and for the periods, indicated therein, subject to<br \/>\nnormal year-end adjustments. The Financial Statements described in subsection<br \/>\n2.21 hereof and the audited balance sheet as of November 30, 1999, as adjusted<br \/>\nby the auditor&#8217;s subsequent event disclosure footnote, shall not show<br \/>\nliabilities due within 18 months from the date thereof in an amount in excess of<br \/>\nOne Million Dollars ($1,000,000) over the amount of cash and cash equivalents<br \/>\nshown on such balance sheet.<\/p>\n<p>                2.23    Except as set forth in the Financial Statements, the<br \/>\nCompany has no liabilities, contingent or otherwise, other than (i) liabilities<br \/>\nincurred in the ordinary course of business and (ii) obligations under contracts<br \/>\nand commitments incurred in the ordinary course of business and not required<br \/>\nunder GAAP to be reflected in the Financial Statements, which, in both cases,<br \/>\nindividually or in the aggregate, are not material to the financial condition or<br \/>\noperating results of the Company.<\/p>\n<p>                2.24    SEC DOCUMENTS, FINANCIAL STATEMENTS. Since November 30,<br \/>\n1999, the Company has timely filed all reports, schedules, forms, statements and<br \/>\nother documents required to be filed by it with the SEC pursuant to the<br \/>\nreporting requirements of the Exchange Act (all of the foregoing filed prior to<br \/>\nthe date hereof and all exhibits included therein and financial statements and<br \/>\nschedules thereto and documents (other than exhibits) incorporated by reference<\/p>\n<p>                                       11<\/p>\n<p>therein, being hereinafter referred to herein as the &#8220;SEC Documents&#8221;). The<br \/>\nCompany has delivered to the Investor, or the Investor has had access to, true<br \/>\nand complete copies of the SEC Documents, except for such exhibits and<br \/>\nincorporated documents. As of their respective dates, the SEC Documents complied<br \/>\nin all material respects with the requirements of the Exchange Act or the<br \/>\nSecurities Act, as the case may be, and the rules and regulations of the SEC<br \/>\npromulgated thereunder applicable to the SEC Documents, and none of the SEC<br \/>\nDocuments, at the time they were filed with the SEC, contained any untrue<br \/>\nstatement of a material fact or omitted to state a material fact required to be<br \/>\nstated therein or necessary in order to make the statements therein, in light of<br \/>\nthe circumstances under which they were made, not misleading. As of their<br \/>\nrespective dates, the consolidated financial statements of the Company included<br \/>\nin the SEC Documents complied as to form in all material respects with<br \/>\napplicable accounting requirements and the published rules and regulations of<br \/>\nthe SEC with respect thereto. Except as disclosed in the SEC Documents, since<br \/>\nNovember 30, 1999, there has been no material adverse change in the assets,<br \/>\nliabilities, business, properties, operations, financial condition, or<br \/>\noperations of the Company on a consolidated basis.<\/p>\n<p>                2.25    NO INTEGRATED OFFERING. Neither the Company, nor any of<br \/>\nits affiliates, nor any person acting on its or their behalf, has directly or<br \/>\nindirectly made any offers or sales in any security or solicited any offers to<br \/>\nbuy any security under circumstances that would require registration under the<br \/>\nSecurities Act of the issuance of the Shares to the Investor. The issuance of<br \/>\nthe Shares to the Investor will not be integrated with any other issuance of the<br \/>\nCompany&#8217;s securities (past, current or future) for purposes of the Securities<br \/>\nAct.<\/p>\n<p>                2.26    YEAR 2000. The mission critical computer software<br \/>\noperated by the Company and each of its subsidiaries is currently capable of<br \/>\nproviding, or is being adapted to provide uninterrupted millennium functionality<br \/>\nto record, store, process and present calendar dates falling on or after January<br \/>\n1, 2000 in substantially the same manner and with the same functionality as such<br \/>\nmission critical software records, stores, processes and processes and presents<br \/>\nsuch calendar dates falling on or before December 31, 1999. The costs of the<br \/>\nadaptations referred to in this clause will not have a Material Adverse Effect.<\/p>\n<p>                                       12<\/p>\n<p>3.      REPRESENTATIONS AND WARRANTIES OF THE INVESTOR.<\/p>\n<p>        The Investor hereby represents and warrants that:<\/p>\n<p>        3.1     AUTHORIZATION. The Investor has full power and authority to<br \/>\nenter into this Agreement. This Agreement constitutes a valid and binding<br \/>\nobligation of the Investor enforceable against the Investor in accordance with<br \/>\nits terms, except (i) as limited by applicable bankruptcy, insolvency,<br \/>\nreorganization, moratorium, and other laws of general application affecting<br \/>\nenforcement of creditors&#8217; rights generally and (ii) as limited by laws relating<br \/>\nto the availability of specific performance, injunctive relief, or other<br \/>\nequitable remedies.<\/p>\n<p>        3.2     PURCHASE ENTIRELY FOR OWN ACCOUNT. The Investor is acquiring the<br \/>\nShares for investment for its own account, not as a nominee or agent, and not<br \/>\nwith a view to, or for the resale or distribution of any part thereof. The<br \/>\nInvestor has no present intention of selling, granting any participation in, or<br \/>\notherwise distributing the same. The Investor further represents that it does<br \/>\nnot have any contract, undertaking, agreement or arrangement with any person to<br \/>\nsell, transfer or grant participations to such person or to any third person,<br \/>\nwith respect to any of the Shares.<\/p>\n<p>        3.3     DISCLOSURE OF INFORMATION. The Investor has received all of the<br \/>\ninformation which it considers necessary or appropriate for deciding whether to<br \/>\npurchase the Shares. The Investor further represents that it has had an<br \/>\nopportunity to ask questions and receive answers from the Company regarding the<br \/>\nterms and conditions of the offering of the Shares. The foregoing, however, does<br \/>\nnot limit or modify the representations and warranties of the Company in Section<br \/>\n2 of this Agreement or the right of the Investor to rely thereon.<\/p>\n<p>        3.4     INVESTMENT EXPERIENCE. The Investor (i) fully understands that<br \/>\nan investment in the Company is highly speculative and that it may lose its<br \/>\nentire investment in the Shares purchased from the Company; (ii) is experienced<br \/>\nin evaluating and investing in development stage companies such as the Company,<br \/>\n(iii) is capable of evaluating the merits and risks of its investment in the<br \/>\nShares; (iv) is able to bear the economic risk of a loss of the entire amount of<br \/>\nits investment in the Shares; and (v) is prepared to hold the Shares for an<br \/>\nindefinite period of time.<\/p>\n<p>                                       13<\/p>\n<p>        3.5     ACCREDITED INVESTOR. The Investor is an &#8220;accredited investor&#8221;<br \/>\nwithin the meaning of Securities and Exchange Commission Rule 501 of<br \/>\nRegulation D, as presently in effect.<\/p>\n<p>        3.6     RESTRICTED SECURITIES. The Investor acknowledges that, because<br \/>\nthe Shares have not been registered under the Securities Act, the Shares must be<br \/>\nheld indefinitely unless subsequently registered under the Securities Act or an<br \/>\nexemption from such registration is available. The Investor is aware of the<br \/>\nprovisions of Rule 144 promulgated under the Securities Act which permits<br \/>\nlimited resale of securities purchased in a private placement subject to the<br \/>\nsatisfaction of certain conditions..<\/p>\n<p>        3.7     LEGENDS. The Investor understands that until (a) the Shares may<br \/>\nbe sold by the Investor under Rule 144(k) or (b) such time as the resale of the<br \/>\nShares have been registered under the Securities Act as contemplated in Section<br \/>\n4.8 hereof, the certificates representing the Shares will bear a restrictive<br \/>\nlegend in substantially the following form (and a stop-transfer order may be<br \/>\nplaced against transfer of the certificates for such Shares):<\/p>\n<p>        THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN<br \/>\n        REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR<br \/>\n        THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. THE<br \/>\n        SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE<br \/>\n        ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE<br \/>\n        SECURITIES UNDER APPLICABLE SECURITIES LAWS, OR UNLESS<br \/>\n        OFFERED, SOLD OR TRANSFERRED PURSUANT TO AN AVAILABLE<br \/>\n        EXEMPTION FROM THE REGISTRATION REQUIREMENT OF THOSE LAWS.<\/p>\n<p>        The legend set forth above will be removed and the Company will issue a<br \/>\ncertificate without the legend to the holder of any certificate upon which it is<br \/>\nstamped, upon registration of the Shares, in accordance with the terms of<br \/>\nSection 4.8 hereof.<\/p>\n<p>                                       14<\/p>\n<p>4.      COVENANTS AND AGREEMENTS<\/p>\n<p>        4.1     ORDINARY COURSE OF BUSINESS AND NOTICE OF ADVERSE CHANGES. From<br \/>\nand after the date of this Agreement through the Closing, the Company shall<br \/>\nconduct its business in the ordinary course and consistent in all material<br \/>\nrespects with past practice, except as may be required or contemplated in this<br \/>\nAgreement. The Company shall advise the Investor promptly of any Material<br \/>\nAdverse Effect, any breach of the Company&#8217;s representations or warranties, or<br \/>\nany breach of a covenant contained herein of which the Company has knowledge.<\/p>\n<p>        4.2     ACCESS TO PROPERTIES AND RECORDS. The Company shall afford to<br \/>\nthe Investor and its respective accountants, counsel and representatives,<br \/>\nreasonable access upon notice to the Company and upon agreed upon times during<br \/>\nnormal business hours throughout the period prior to the Closing to all of the<br \/>\nCompany&#8217;s properties, books, contracts, commitments and written records and<br \/>\nshall make reasonably available its respective officers and employees to answer<br \/>\nfully and promptly questions put to them (so long as such questions are not<br \/>\noutside of the scope or purpose of this Section; provided that such access shall<br \/>\nnot unreasonably interfere with the normal business operations of the Company).<br \/>\nAny such investigations shall be specifically related to this Agreement and to<br \/>\nthe transactions contemplated hereby.<\/p>\n<p>        4.3     EXCLUSIVE NEGOTIATIONS. Except in the furtherance of the<br \/>\ntransactions contemplated herein, prior to the Closing, the Company shall not<br \/>\ndirectly, and shall use its reasonable best efforts to cause its respective<br \/>\ndirectors, officers, employees, representatives or agents (including, without<br \/>\nlimitation, any investment banker, attorney or accountant retained by it or any<br \/>\nof its affiliates) not to, directly or indirectly, initiate, solicit or<br \/>\nencourage any inquiries or the making or implementation of any proposal or<br \/>\noffer, with respect to any merger, acquisition, consolidation, share exchange,<br \/>\nbusiness combination or other transaction involving, or which would result in<br \/>\nthe acquisition of a majority of the outstanding equity securities or<br \/>\nsubstantially all of the assets of the Company (any such proposal or offer being<br \/>\nhereinafter referred to as an &#8220;Acquisition Proposal&#8221;), or engage in any<br \/>\nnegotiations concerning, or provide any confidential information or data to, any<br \/>\nperson or entity relating to an Acquisition Proposal, or otherwise facilitate<br \/>\nany effort or attempt to make or implement an Acquisition Proposal. The Company<br \/>\nshall immediately cease and cause to be terminated any existing activities or<br \/>\nnegotiations with any parties conducted heretofore with respect to any<br \/>\nAcquisition Proposal, and <\/p>\n<p>                                       15<\/p>\n<p>it shall take the necessary steps to inform any such parties of the obligations<br \/>\nundertaken in this Section. The Company shall notify the Buyer immediately if<br \/>\nany such inquiries or proposals are received by, any such information is<br \/>\nrequested from, or any such negotiations are sought to be initiated or continued<br \/>\nwith, the Company.<\/p>\n<p>        4.4     RIGHT OF FIRST REFUSAL. If, during the period from the Closing<br \/>\nthrough December 31, 2009 (and so long as the Alliance Agreement is in effect),<br \/>\nthe Company (or any subsidiary or affiliate) proposes either to sell, transfer<br \/>\nor assign, directly or indirectly, securities in the Company or any subsidiary<br \/>\nor affiliate thereof equal to, or convertible into, a majority of the<br \/>\noutstanding Common Stock of the Company (a &#8220;Substantial Equity Interest&#8221;), the<br \/>\nInvestor shall have a first right of refusal to purchase such Substantial Equity<br \/>\nInterest proposed to be sold, transferred or assigned, for a price equivalent to<br \/>\nthe bona fide sale or transfer price offered for such Substantial Equity<br \/>\nInterest and otherwise in accordance with the terms and conditions of such<br \/>\noffer. The right of first refusal granted to the Investor is intended to apply<br \/>\nto any sale, transfer or assignment, directly or indirectly, to any nominee or<br \/>\nstraw-men, corporation or other entity, including the sale of stock or an<br \/>\ninterest in a partnership, limited-liability corporation, trust or other entity<br \/>\nwhich holds substantially all of the assets of the Company or any of its<br \/>\nsubsidiaries or affiliates, if the intent of any such sale, transfer or<br \/>\nassignment to such person or entity is to avoid the Investor&#8217;s right of first<br \/>\nrefusal contained in this Section.<\/p>\n<p>        4.5     PREEMPTIVE RIGHT OF INVESTOR.<\/p>\n<p>                (i)     The Company hereby grants to the Investor the preemptive<br \/>\nright to purchase its Pro Rata Share (defined below) of any New Securities<br \/>\n(defined below) that the Company intends to offer for sale and issuance at the<br \/>\ntime and on the terms set forth herein (the &#8220;Preemptive Right&#8221;).<\/p>\n<p>                (ii)    DEFINITIONS:<\/p>\n<p>                        (1)     &#8220;New Securities&#8221; shall mean (A) any Common Stock<br \/>\nof the Company and (B) those rights, options or warrants to purchase any such<br \/>\nCommon Stock (collectively referred to as &#8220;Options&#8221;), and those securities that<br \/>\nare convertible into or exchangeable for any such Common Stock (collectively<br \/>\nreferred to as &#8220;Convertible Securities&#8221;), <\/p>\n<p>                                       16<\/p>\n<p>if the gross proceeds received or receivable by the Company as consideration for<br \/>\nthe issue of such Common Stocks, Options or Convertible Securities, plus the<br \/>\nminimum aggregate amount of additional consideration (as set forth in the<br \/>\ninstruments relating thereto, without regard to any provision contained therein<br \/>\ndesignated to protect against dilution) payable to the Company upon the exercise<br \/>\nof such Options or the conversion or exchange of such Convertible Securities,<br \/>\nequals or exceeds One Million Five Hundred Thousand Dollars ($1,500,000);<br \/>\nprovided however, that &#8220;New Securities&#8221; does not include (i) any capital stock<br \/>\nor other securities offered or issued to the public pursuant to a registration<br \/>\nstatement filed under the Securities Act; (ii) any capital stock or other<br \/>\nsecurities offered or issued in connection with any acquisition of another<br \/>\ncorporation or entity by the Company by merger or purchase of all, or<br \/>\nsubstantially all, of the assets of such corporation or entity, share exchange,<br \/>\nreorganization or the like; (iii) any stock options granted, subsequent to the<br \/>\nEffective Date, to the Company&#8217;s existing or future directors, employees or<br \/>\nconsultants not in excess of 1,350,000 shares, representing approximately eight<br \/>\npoint two percent (8.2%) of the Company&#8217;s 16,458,114 aggregate issued and<br \/>\noutstanding shares of common stock post-Closing (on a fully-diluted basis) by<br \/>\nthe Company; (iv) any capital stock or other securities (or related options or<br \/>\nwarrants) offered or issued to directors, officers or employees of, or<br \/>\nconsultants to, the Company pursuant to an agreement or an option or purchase<br \/>\nplan program, or any other stock incentive plan or program approved by the Board<br \/>\nof Directors of the Company; or (v) any capital stock or other securities issued<br \/>\nin connection with any stock split, stock dividend, recapitalization or the like<br \/>\nby the Company.<\/p>\n<p>                        (2)     &#8220;Ownership Ratio&#8221; shall mean the ratio of shares<br \/>\nof Common Stock of the Company held by the Investor on the day immediately<br \/>\npreceding the date of the notice described in subsection (c) below to the total<br \/>\nnumber of shares of Common Stock of the Company then outstanding.<\/p>\n<p>                        (3)     &#8220;Pro Rata Share&#8221; for purposes of the Preemptive<br \/>\nRight, shall mean all New Securities which the Company intends to offer for sale<br \/>\nmultiplied by the Investor&#8217;s Ownership Ratio.<\/p>\n<p>                (iii)   If at any time from the Closing through December 31,<br \/>\n2009, the Company plans or otherwise intends to undertake an issuance of New<br \/>\nSecurities, the Company <\/p>\n<p>                                       17<\/p>\n<p>shall, so long as the Alliance Agreement is in effect, give the Investor written<br \/>\nnotice describing the type of New Securities, the price, and the general terms<br \/>\nupon which the Company plans or otherwise intends to issue the same. The<br \/>\nInvestor shall have fifteen (15) days from the date of delivery of any such<br \/>\nnotice to agree to purchase all or a portion of its Pro Rata Share of such New<br \/>\nSecurities for the price and upon the general terms specified in the notice by<br \/>\ngiving written notice to the Company at or before the end of such fifteen (15)<br \/>\ndays. If the Investor either fails to so notify the Company or indicates that it<br \/>\nwill not purchase its Pro Rata Share, the Company shall thereafter be free to<br \/>\noffer, sell and issue the New Securities, including any such Pro Rata Share not<br \/>\npurchased by the Investor, to any third party so long as such sale is at a price<br \/>\nand is upon general terms no more favorable than described in the Company&#8217;s<br \/>\nnotice.<\/p>\n<p>                4.6     CERTAIN EMPLOYMENT MATTERS. Effective as of the date of<br \/>\nthe Closing, there are no employment agreements to which the Company is a party<br \/>\nother than those set out in the tabled attached as Schedule 4.6 hereto.<\/p>\n<p>                4.7     BOARD OBSERVER. The Company hereby covenants and agrees<br \/>\nwith Investor that, as long as the Alliance Agreement (defined below) remains in<br \/>\neffect, the Investor shall have the right to designate a person (an &#8220;Observer&#8221;)<br \/>\nto be present at all meetings of the Board of Directors of the Company and all<br \/>\ncommittees thereof. The Company will give such Observer reasonable prior notice<br \/>\n(it being agreed that the same prior notice given to the Board of Directors<br \/>\nshall be deemed reasonable prior notice) in any manner permitted in the<br \/>\nCompany&#8217;s By-laws for notices to directors of the time and place of any proposed<br \/>\nmeeting of the Board of Directors, such notice in all cases to include true and<br \/>\ncomplete copies of all documents furnished to any director in connection with<br \/>\nsuch meeting. Such Observer will be entitled to be present in person as an<br \/>\nobserver at any such meeting or, if a meeting is held by telephone conference,<br \/>\nto participate therein for the purpose of listening thereto.<\/p>\n<p>                4.8     REGISTRATION OF SHARES. The Company covenants and agrees<br \/>\nthat it shall promptly after the Closing prepare and file, at its cost and<br \/>\nexpense, a registration statement on Form S-1 (or such other appropriate form)<br \/>\ncovering the Shares (the &#8220;Registration Statement&#8221;) and shall use its best<br \/>\nefforts to cause such registration statement to be declared effective within 90<br \/>\ndays following the Closing. The Company further covenants and agrees to maintain<br \/>\nthe <\/p>\n<p>                                       18<\/p>\n<p>Registration Statement Effective for one year following the effective date of<br \/>\nthe Registration Statement, PROVIDED, THAT, notwithstanding the foregoing, if at<br \/>\nany time or from time to time after the date of effectiveness of the<br \/>\nRegistration Statement, the Company notifies the Investors in writing of the<br \/>\nexistence of a Potential Material Event, the Investors shall not offer or sell<br \/>\nany Shares, or engage in any other transaction involving or relating to the<br \/>\nShares, from the time of the giving of notice with respect to a Potential<br \/>\nMaterial Event until such Investor receives written notice from the Company that<br \/>\nsuch Potential Material Event either has been disclosed to the public or no<br \/>\nlonger constitutes a Potential Material Event; PROVIDED, HOWEVER, that the<br \/>\nCompany may not so suspend such right to the Investor during the period the<br \/>\nRegistration Statement is required to be in effect for more than fifty (50)<br \/>\ndays, provided, however, that no one such suspension period shall either (i) be<br \/>\nfor more than twenty (20) days or (ii) begin less than ten (10) business days<br \/>\nafter the last day of the preceding suspension. As used herein, &#8220;Potential<br \/>\nMaterial Event&#8221; means any of the following: (i) the possession by the Company of<br \/>\nmaterial information not ripe for disclosure in a registration statement, which<br \/>\nshall be evidenced by determinations in good faith by the Board of Directors of<br \/>\nthe Company that disclosure of such information in the registration statement<br \/>\nwould be detrimental to the business and affairs of the Company; or (ii) any<br \/>\nmaterial engagement or activity by the Company which would, in the good faith<br \/>\ndetermination of the Board of Directors of the Company, be adversely affected by<br \/>\ndisclosure in a registration statement at such time, which determination shall<br \/>\nbe accompanied by a good faith determination by the Board of Directors of the<br \/>\nCompany that the registration statement would be materially misleading absent<br \/>\nthe inclusion of such information.<\/p>\n<p>        In the event that the Registration Statement is not declared effective<br \/>\nwithin 90 days following Closing, then the Company shall issue to the Investor,<br \/>\nin respect of each full calendar week (beginning on Monday) following such 90th<br \/>\nday and continuing until such time as the Registration Statement shall have been<br \/>\ndeclared effective, such number of shares of Common Stock as shall be equal to<br \/>\none and one quarter percent (1 1\/4%) of the number of Shares issued hereunder<br \/>\n(the &#8220;Additional Shares&#8221;), PROVIDED, THAT, notwithstanding anything to the<br \/>\ncontrary contained in the foregoing, the Company shall have no obligation to<br \/>\nissue any Additional Shares in excess of such number of Additional Shares as<br \/>\nshall be equal to, in the aggregate, 10% of the number of Shares issued<br \/>\nhereunder.<\/p>\n<p>                                       19<\/p>\n<p>        REPORTING STATUS; ELIGIBILITY TO USE FORM S-1. The Company&#8217;s Common<br \/>\nStock is registered under Section 12 of the Exchange Act. The Company will file<br \/>\nwith the SEC a Current Report on Form 8-K disclosing this Agreement and the<br \/>\ntransactions contemplated hereby within 10 business days after the Closing.<br \/>\nThroughout the one year registration period (referred to in Section 4.8 hereof),<br \/>\nthe Company shall to file all reports, schedules, forms, statements and other<br \/>\ndocuments required to be filed by it timely with the SEC under the reporting<br \/>\nrequirements of the Exchange Act, and the Company will not terminate its status<br \/>\nas an issuer required to file reports under the Exchange Act even if the<br \/>\nExchange Act or the rules and regulations thereunder would permit such<br \/>\ntermination. The Company currently meets, and will take all reasonably necessary<br \/>\naction to continue to meet, the &#8220;registrant eligibility&#8221; requirements set forth<br \/>\nin the general instructions to Form S-1.<\/p>\n<p>5.      CONDITIONS OF INVESTOR&#8217;S OBLIGATIONS AT CLOSING.<\/p>\n<p>        The obligations of the Investor under subsection 1.1 of this Agreement<br \/>\nare subject to the fulfillment, or written waiver by the Investor, on or before<br \/>\nthe Closing of each of the following conditions:<\/p>\n<p>        5.1     EXECUTION OF AGREEMENT. The Company will have executed and<br \/>\ndelivered this Agreement to the Investor.<\/p>\n<p>        5.2     SHARES CERTIFICATE. The Company will have delivered to the<br \/>\nInvestors duly executed certificates representing the Shares in the amounts<br \/>\nspecified in Section 1.1 hereof.<\/p>\n<p>        5.3     REPRESENTATIVES, WARRANTIES, COVENANTS. The representations and<br \/>\nwarranties of the Company must be true and correct in all material respects as<br \/>\nof the Closing as though made at that time (except for representations and<br \/>\nwarranties that speak as of a specific date, which representations and<br \/>\nwarranties must be true and correct as of such date) and the Company must have<br \/>\nperformed and complied in all material respects with the covenants and<br \/>\nconditions required by this Agreement to be performed or complied with by the<br \/>\nCompany at or prior to the Closing. The Investor must have received a<br \/>\ncertificate or certificates dated as of the Closing and executed by the Chief<br \/>\nExecutive Officer or the Chief Financial Officer of the Company certifying as to<br \/>\nthe matters contained in this Section 5.3 and as to such other matters as may be<br \/>\nreasonably requested by such Investor, including, but not limited to, the<br \/>\nCompany&#8217;s <\/p>\n<p>                                       20<\/p>\n<p>Certificate of Incorporation, as amended, By-laws, as amended, Board of<br \/>\nDirectors&#8217; resolutions relating to the transactions contemplated hereby and the<br \/>\nincumbency and signatures of each of the officers of the Company who may execute<br \/>\non behalf of the Company any document delivered at the Closing.<\/p>\n<p>        5.4     LITIGATION. No litigation, statute, rule, regulation, executive<br \/>\norder, decree, ruling or injunction will have been enacted, entered, promulgated<br \/>\nor endorsed by or in any court or governmental authority of competent<br \/>\njurisdiction or any self-regulatory organization having authority over the<br \/>\nmatters contemplated hereby which prohibits the consummation of any of the<br \/>\ntransactions contemplated by this Agreement.<\/p>\n<p>        5.5     STOCK LISTING. Trading and listing of the Company&#8217;s Common Stock<br \/>\non OTC Electronic Bulletin Board must not have been suspended.<\/p>\n<p>        5.6     OPINION. The Investor will have received an opinion of the<br \/>\nCompany&#8217;s general counsel, dated as of the Closing, in form, scope and substance<br \/>\nsubstantially in the form attached hereto as SCHEDULE 5.6.<\/p>\n<p>        5.7     ALLIANCE AGREEMENT. Prior to or simultaneous with the Closing,<br \/>\nthe Company and Investor shall have entered into the Alliance Agreement,<br \/>\nsubstantially in the form of SCHEDULE 5.7 hereto.<\/p>\n<p>6.      CONDITIONS OF THE COMPANY&#8217;S OBLIGATIONS AT CLOSING.<\/p>\n<p>        The obligations of the Company to the Investor under this Agreement are<br \/>\nsubject to the fulfillment on or before the Closing of each of the following<br \/>\nconditions: <\/p>\n<p>        6.1 EXECUTION OF AGREEMENT. The Investor will have executed and<br \/>\ndelivered this Agreement to the Company.<\/p>\n<p>        6.2     PURCHASE PRICE. The Investor will have delivered the Purchase<br \/>\nPrice for the Shares to the Company in accordance with this Agreement.<\/p>\n<p>        6.3     REPRESENTATIONS, WARRANTIES, COVENANTS. The representations and<br \/>\nwarranties of the Investor must be true and correct in all material respects as<br \/>\nof the Closing as <\/p>\n<p>                                       21<\/p>\n<p>though made at that time (except for representations and warranties that speak<br \/>\nas of a specific date, which representations and warranties must be correct as<br \/>\nof such date), and the Investor will have performed and complied in all material<br \/>\nrespects with the covenants and conditions required by this Agreement to be<br \/>\nperformed or complied with by the Investor at or prior to the Closing. The<br \/>\nCompany must have received a certificate or certificates dated as of the Closing<br \/>\nand executed by a duly authorized officer of the Investor certifying as to the<br \/>\nmatters contained in this Section 6.3.<\/p>\n<p>        6.4     LEGAL IMPEDIMENT. No statute, rule, regulation, executive order,<br \/>\ndecree, ruling or injunction will have been enacted, entered, promulgated or<br \/>\nendorsed by or in any court or governmental authority of competent jurisdiction<br \/>\nor any self-regulatory organization having authority over the matters<br \/>\ncontemplated hereby which prohibits the consummation of any of the transactions<br \/>\ncontemplated by this Agreement.<\/p>\n<p>        6.5     ALLIANCE AGREEMENT. Prior to or simultaneous with the Closing,<br \/>\nthe Company and Investor shall have entered into the Alliance Agreement,<br \/>\nsubstantially in the form of SCHEDULE 5.7 hereto.<\/p>\n<p>7.      DEFINITIONS.<\/p>\n<p>        7.1     &#8220;Alliance Agreement&#8221; has the meaning set forth in Section 5.7.<\/p>\n<p>        7.2     &#8220;Closing&#8221; means the closing of the purchase and sale of the<br \/>\nShares under this Agreement.<\/p>\n<p>        7.3     &#8220;Common Stock&#8221; means the common stock, $0.001 par value per<br \/>\nshare, of the Company.<\/p>\n<p>        7.4     &#8220;Company&#8221; means TTR Technologies, Inc.<\/p>\n<p>        7.5     &#8220;Exchange Act&#8221; means the Securities Exchange Act of 1934, as<br \/>\namended.<\/p>\n<p>        7.6     &#8220;Investor&#8221; means Macrovision Corporation<\/p>\n<p>        7.7     &#8220;Material Adverse Effect&#8221; means a material adverse effect on<br \/>\n(a) the business, operations, assets or financial condition of the Company on a<br \/>\nconsolidated basis or <\/p>\n<p>                                       22<\/p>\n<p>(b) the ability of the Company to perform its obligations pursuant to the<br \/>\ntransactions contemplated by this Agreement or under the agreements or<br \/>\ninstruments to be entered into or filed in connection herewith.<\/p>\n<p>                7.8     &#8220;Material Agreement&#8221; has the meaning set forth in<br \/>\nSection 2.7.<\/p>\n<p>                7.9     &#8220;Regulation D&#8221; means Regulation D as promulgated under<br \/>\nby the SEC under the Securities Act.<\/p>\n<p>                7.10    &#8220;Rule 144&#8221; and &#8220;Rule 144(k)&#8221; mean Rule 144 and Rule<br \/>\n144(k), respectively, promulgated under the Securities Act, or any successor<br \/>\nrule.<\/p>\n<p>                7.11    &#8220;SEC&#8221; means the United States Securities and Exchange<br \/>\nCommission.<\/p>\n<p>                7.12    &#8220;SEC Documents&#8221; has the meaning set forth in<br \/>\nSection 2.23.<\/p>\n<p>                7.13    &#8220;Shares&#8221; means the 1,880,937 shares of Common Stock to<br \/>\nbe sold to Investor pursuant to this Agreement, as such number may be adjusted<br \/>\npursuant to the provisions of Section 4.8 hereof.<\/p>\n<p>                7.14    &#8220;Securities Act&#8221; means the Securities Act of 1933, as<br \/>\namended, and the rules and regulations thereunder, or any similar successor<br \/>\nstatute.<\/p>\n<p>        8.      MISCELLANEOUS.<\/p>\n<p>                8.1     SURVIVAL OF WARRANTIES. The warranties, representations<br \/>\nand covenants of the Company and the Investor contained in or made pursuant to<br \/>\nthis Agreement shall survive the execution and delivery of this Agreement and<br \/>\nthe Closing and shall in no way be affected by any investigation of the subject<br \/>\nmatter thereof made by or on behalf of the Investor of the Company.<\/p>\n<p>                8.2     SUCCESSOR AND ASSIGNS. Except as otherwise provided<br \/>\nherein, the terms and conditions of this Agreement shall inure to the benefit of<br \/>\nand be binding upon the respective successors and assigns of the parties<br \/>\n(including transferees of any Shares). Nothing in this Agreement, express or<br \/>\nimplied, is intended to confer upon any party other than the parties hereto or<br \/>\ntheir respective successors and assigns any rights, remedies, obligations, or<br \/>\nliabilities under or by reason of this Agreement, except as expressly provided<br \/>\nin this Agreement.<\/p>\n<p>                                       23<\/p>\n<p>                8.3     GOVERNING LAW. This Agreement shall be governed by and<br \/>\nconstrued under the laws of the State of California as applicable to contracts<br \/>\nto be performed entirely within that state.<\/p>\n<p>                8.4     COUNTERPARTS. This Agreement may be executed in two or<br \/>\nmore counterparts, each of which shall be deemed an original by the party<br \/>\nexecuting the same, but all of which together shall constitute one and the same<br \/>\ninstrument.<\/p>\n<p>                8.5     TITLES AND SUBTITLES. The titles and subtitles used in<br \/>\nthis Agreement are used for convenience and are not to be considered in<br \/>\nconstruing or interpreting this Agreement.<\/p>\n<p>                8.6     NOTICES. All notices and other communications given or<br \/>\nmade pursuant hereto shall be in writing and shall be deemed to have been given<br \/>\nor made if in writing and (i) delivered personally, (ii) mailed by registered or<br \/>\ncertified mail (postage prepaid, return receipt requested) or (iii) sent by<br \/>\ntelecopier, with the written notice sent by mail as set forth in (ii) above, to<br \/>\nthe parties as follows:<\/p>\n<p>                   (i)   if to Company to:<\/p>\n<p>                   TTR Technologies, Inc., c\/o TTR Technologies Ltd.<br \/>\n                   2 Hanagar Street<br \/>\n                   PO Box 2295<br \/>\n                   Kfar-Saba 44425<br \/>\n                   Israel<br \/>\n                   Attention:  General Counsel<br \/>\n                   Telecopier No.:  011-972-9-766-2394<\/p>\n<p>                   with a copy to:<\/p>\n<p>                   Aboudi &amp; Brounstein<br \/>\n                   136 Rothschild Blvd.<br \/>\n                   Tel Aviv 65272<br \/>\n                   Israel<br \/>\n                   Telecopier No.  011-972-3-685-1138<\/p>\n<p>                   (ii)     if to Investor to:<\/p>\n<p>                   Macrovision Corporation<br \/>\n                   1341 Orleans Drive<br \/>\n                   Sunnyvale, CA 94089<br \/>\n                   Attention:  Chief Financial Officer<br \/>\n                   Telecopier No.: (408) 743-8610<\/p>\n<p>                                       24<\/p>\n<p>                   with a copy to:<\/p>\n<p>                   Manatt, Phelps &amp; Phillips, LLP<br \/>\n                   3030 Hansen Way<br \/>\n                   Palo Alto, CA  94304<br \/>\n                   Attention:  David Herbst, Esq.<br \/>\n                   Telecopier No.:  (650) 213-0260<\/p>\n<p>or at such other addresses as shall be furnished by the parties by like notice,<br \/>\nand such notice or communication shall be deemed to have been given or made as<br \/>\nof the date so delivered, mailed or sent.<\/p>\n<p>        8.7     FINDER&#8217;S FEE. Each party represents that it neither is nor will<br \/>\nbe obligated for any finders&#8217; fee or commission in connection with this<br \/>\ntransaction. The Investor agrees to indemnify and to hold harmless the Company<br \/>\nfrom any liability for any commission or compensation in the nature of a<br \/>\nfinders&#8217; fee (and the costs and expenses of defending against such liability or<br \/>\nasserted liability) for which the Investor or any of its officers, partners,<br \/>\nemployees, or representatives is responsible. The Company agrees to indemnify<br \/>\nand hold harmless the Investor from any liability for any commission or<br \/>\ncompensation in the nature of a finders&#8217; fee (and the costs and expenses of<br \/>\ndefending against such liability or asserted liability) for which the Company or<br \/>\nany of its officers, employees or representatives is responsible.<\/p>\n<p>        8.8     EXPENSES. Irrespective of whether the Closing is effected, the<br \/>\nCompany and the Investor shall each pay their own costs and expenses that each<br \/>\nincurs with respect to the negotiation, execution, delivery and performance of<br \/>\nthis Agreement. If any action at law or in equity is necessary to enforce or<br \/>\ninterpret the terms of this Agreement, the prevailing party shall be entitled to<br \/>\nreasonable attorney&#8217;s fees, costs and necessary disbursements in addition to any<br \/>\nother relief to which such party may be entitled.<\/p>\n<p>        8.9     AMENDMENTS AND WAIVERS. Any term of this Agreement may be<br \/>\namended and the observance of any term of this Agreement may be waived (either<br \/>\ngenerally or in a particular instance and either retroactively or<br \/>\nprospectively), only with the written consent of the Company and the Investor.<\/p>\n<p>                                       25<\/p>\n<p>        8.10    SEVERABILITY. If one or more provisions of this Agreement are<br \/>\nheld to be unenforceable under applicable law, such provision shall be excluded<br \/>\nfrom this Agreement and the balance of the Agreement shall be interpreted as if<br \/>\nsuch provision were so excluded and shall be enforceable in accordance with its<br \/>\nterms.<\/p>\n<p>        8.11    ENTIRE AGREEMENT. This Agreement, together with the Alliance<br \/>\nAgreement, and all schedules and exhibits attached thereto, constitute the<br \/>\nentire agreement among the parties and no party shall be liable or bound to any<br \/>\nother party in any manner by any warranties, representations, or covenants<br \/>\nexcept as specifically set forth herein or therein. All other prior agreements,<br \/>\nunderstandings and representations, both oral and written, between the parties<br \/>\nwith respect to the subject matter hereof are superseded and of no effect. This<br \/>\nAgreement may be executed in counterparts and by the exchange of facsimile<br \/>\nsigned copies.<\/p>\n<p>        IN WITNESS WHEREOF, the parties have executed this Stock Purchase<br \/>\nAgreement.<\/p>\n<p>                             TTR TECHNOLOGIES, INC.<\/p>\n<p>                             BY:<br \/>\n                                &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                   Name:<br \/>\n                                        &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                   Title:<br \/>\n                                        &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                             MACROVISION CORPORATION<\/p>\n<p>                             BY:<br \/>\n                                &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                   Name:<br \/>\n                                        &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                   Title:<br \/>\n                                        &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                       26<\/p>\n<p>                                   SCHEDULE A<\/p>\n<p>                             SCHEDULE OF EXCEPTIONS<\/p>\n<p>        The following information and disclosures is provided with respect to<br \/>\nthe representations and warranties of the Company to the Investor set forth in<br \/>\nSection 2 of the Agreement and corresponding to the relevant subsection of the<br \/>\nAgreement.<\/p>\n<p>SECTION 2.2(b).<\/p>\n<p>        The Company has outstanding the following warrants\/options issued to<br \/>\nservice providers\/consultants:<\/p>\n<p>        (i)     Wall &amp; Broad (1,300,000). Issued in May, 1999 and exercisable<br \/>\nthrough April 30, 2002 at an ex. price per share of $0.01<\/p>\n<p>        (ii)    K &amp; D Equities Inc. (400,000). Issued in July 1999 and<br \/>\nexercisable through Jan. 31, 2001 at an ex. Price per share of $2.75 (2)<\/p>\n<p>        (iii)   Machtec Ltd. (1,000,000). Issued in Aug. 1999 and exercisable<br \/>\nthrough Oct. 2002 at an ex. Price per share of $0.01.<\/p>\n<p>        (iv)    Plans Inc. (25,000). Issued in June 98 and exercisable through<br \/>\nJune 2002 at an exercise price of $1.50 per share.<\/p>\n<p>        (v)     Josephthal (25,000). Undertook to issue in April 98 and<br \/>\nexercisable through June 2002 at an ex. Price per share of $5 5\/8. (3)<\/p>\n<p>        (vi)    Shavit (10,069)<\/p>\n<p>        (vii)   Mu &amp; Kang (10,000) Issued in Jan 99 and exercisable through<br \/>\nJan 2002 at an ex. Price per share of $1.75<\/p>\n<p>        (viii)  (196,000) three year penny warrants issued to Employees of the<br \/>\nCompany in Feb. 1999.<\/p>\n<p>        (ix)    (25,000) three year penny warrants issued to Schneider Ehrlich<br \/>\nin Nov. 99.<\/p>\n<p>       The Company has the following warrants\/options outstanding to investors.<\/p>\n<p>        (i)     Warrants held by certain private placement investors issued<br \/>\nbetween April &#8217;98 through Dec. &#8217;98 to purchase up to an aggregate of 150,842<br \/>\nshares of Common Stock<\/p>\n<p>        (ii)    Biscount (33,000). Issued in Jan 98 in connection with<br \/>\ninvestment in Company and are exercisable through Dec 2001 at an ex. Price per<br \/>\nshare of $7.80)<\/p>\n<p>                                       27<\/p>\n<p>        (iii)   (15,000). Issued in Nov. 99 and exercisable through Nov. 2002 at<br \/>\nan ex. Price per share of $2.50<\/p>\n<p>        (iv)    (35,000) Issued in Nov. 99 and exercisable through Nov. 2002 at<br \/>\nan ex. Price per share of $3.50.<\/p>\n<p>        The Company also has outstanding 749,400 ESOPs.<\/p>\n<p>SECTION 2.2 (c)<\/p>\n<p>        In May 1999 the Company granted to certain investors the right of first<br \/>\nrefusal, under certain conditions, with respect to the issuance by the Company<br \/>\nof shares of common stock or securities convertible into its common stock, which<br \/>\nright is exercisable from October 6, 1999 through approximately July 6, 2000.<\/p>\n<p>SECTION 2.14(a)<\/p>\n<p>        The Company granted exclusive production and marketing rights for<br \/>\nDiscGuard to China Intercontinental Communications Center for the People&#8217;s<br \/>\nRepublic of China, Taiwan, and Maco.<\/p>\n<p>        Sonopress Gmbh holds a non-exclusive license to manufacture and market<br \/>\nDiscGuard and related products in the world, except for the Peoples Republic in<br \/>\nChina (PRC).<\/p>\n<p>        Nimbus CD International Inc. holds a non-exclusive worldwide license to<br \/>\nmanufacture and market DiscGuard and related products.<\/p>\n<p>        Warlock Records holds a non exclusive worldwide license to use<br \/>\nMusicGuard protection for their music CDs.<\/p>\n<p>SECTION 2.14(b)<\/p>\n<p>        TTR licenses form Elektroson BV a product known as Gear. Wks Toolkit for<br \/>\nwhich it pays royalties and which is used in the process of producing DiscGuard<br \/>\nprotected discs.<\/p>\n<p>SECTION 2.17<\/p>\n<p>        TTR has previously granted to Machtec Ltd. registration rights<br \/>\nrespecting up to 200,000 shares of the Company&#8217;s Common Stock and options to<br \/>\nacquire in the aggregate up to 1,000,000 shares of the Company&#8217;s Common Stock.<\/p>\n<p>        Additionally, certain consultants\/employees have been granted<br \/>\nregistration rights with respect to a total of approximately 500,000 shares of<br \/>\nCommon Stock.<\/p>\n<p>        Additionally, the Company currently has outstanding an effective<br \/>\nregistration statement in favor of certain of its stockholders and rightsholders<br \/>\n[Registration No. 333-85085], which the Company is required to maintain<br \/>\neffective through the earlier of Oct. 2001 or the disposition of the subject<br \/>\nshares.<\/p>\n<p>                                       28<\/p>\n<p>SECTION 2.18<\/p>\n<p>        The Company has not filed its United States Income tax returns for the<br \/>\nyear ended December 31, 1998.<\/p>\n<p>SECTION 2.20<\/p>\n<p>        The Company does not presently have in effect any insurance policies<br \/>\nwith respect to fire, public liability, property damage or any other insurance.<\/p>\n<p>                                       29<\/p>\n<p>                                  SCHEDULE 4.6<\/p>\n<p>        Emanuel Kronitz, Dr. Baruch Sollish, Marc D. Tokayer, Gershon Tokayer,<br \/>\nRobert Friedman, Joseph Cusamaro and Rachel Uzan. The agreements with Messrs.<br \/>\nFriedman and Cusamaro are expected to terminate by no later than January 31,<br \/>\n2000.<\/p>\n<p>                                       30<\/p>\n<p>                                  SCHEDULE 5.6<\/p>\n<p>                          OPINION OF COMPANY&#8217;S COUNSEL<\/p>\n<p>                                January 12, 2000<\/p>\n<p>Macrovision Corporation (&#8220;Investor&#8221;)<br \/>\n1341 Orleans Drive<br \/>\nSunnyvale, California  94089<\/p>\n<p>Gentlemen:<\/p>\n<p>        As General Counsel of TTR Technologies, Inc., a Delaware corporation<br \/>\n(the &#8220;Company&#8221;), we represented the Company in connection with the issuance of<br \/>\n1,880,937 shares (the &#8220;Shares&#8221;) of the Company&#8217;s Common Stock, $0.001 par value<br \/>\nper share, pursuant to that certain Stock Purchase Agreement, dated as of<br \/>\nJanuary 10, 2000, including the exhibits thereto (the &#8220;Agreement&#8221;), between the<br \/>\nCompany and the Investor. This opinion is being delivered to you pursuant to<br \/>\nSection 5.6 of the Agreement. Capitalized terms used herein are as defined in<br \/>\nthe Agreement unless otherwise specifically provided herein.<\/p>\n<p>        In rendering the opinions set forth below I have examined such documents<br \/>\nand have reviewed such questions of law as I have considered necessary or<br \/>\nappropriate for the purpose of this opinion.<\/p>\n<p>        In rendering the opinions set forth below, I have, with your consent,<br \/>\nassumed without investigation, that:<\/p>\n<p>        1.      All documents submitted to me as originals are complete and<br \/>\nauthentic; all copies of documents submitted to me conform in all respects to<br \/>\nthe originals thereof, including all modifications or amendments thereto; all<br \/>\nsignatures to documents are genuine; all originals or copies submitted to me<br \/>\nhave not been amended, modified or terminated since the date they were submitted<br \/>\nto me by written or oral agreement of the parties thereto, by the conduct of the<br \/>\nparties thereto or otherwise; facsimile signatures have the same legal effect as<br \/>\noriginal signatures; and all representations and certificates as to factual<br \/>\nmatters dated prior to or on the date hereof upon which I have relied are and<br \/>\nremain accurate, adequate and complete on and as of the date hereof; and each<br \/>\nnatural person signing a document is a competent adult person of sound mind not<br \/>\noperating under any legal disability, duress or fraud.<\/p>\n<p>        2.      The Agreement accurately reflects all of the terms, provisions<br \/>\nand conditions of the transactions contemplated thereby and the intent of the<br \/>\nparties with respect thereto, and that there is no usage of trade or course of<br \/>\nconduct among the parties thereto which would modify the terms of the Agreement<br \/>\nor the respective rights or obligation of the parties thereunder.<\/p>\n<p>        3.      All of the factual representations made by Company and the<br \/>\nInvestor in the Agreement are true and correct. As to questions of fact material<br \/>\nto this opinion, we have relied upon and assumed the accuracy of, without any<br \/>\nindependent investigation on our part, certain representations made by the<br \/>\nCompany and such other facts as are actually known to us.<\/p>\n<p>                                       31<\/p>\n<p>        4.      The Agreement will be enforced and performed in good faith and<br \/>\nin a commercially reasonable manner.<\/p>\n<p>        5.      The conduct of all parties to the Agreement conforms, and in the<br \/>\nfuture will conform, with all notice requirements in statutes, law rules,<br \/>\nregulations and ordinances, unless such notice requirements have been validly<br \/>\nand legally waived.<\/p>\n<p>        6.      The Agreement has been duly authorized, executed and delivered<br \/>\nby the Investor and Investor has the power and authority (corporate or<br \/>\notherwise) to execute and deliver the Agreement.<\/p>\n<p>                Based upon and subject to the foregoing, we are of the opinion<br \/>\nthat:<\/p>\n<p>        1.      The Company is a corporation duly incorporated, validly existing<br \/>\nand in good standing under the laws of the State of Delaware, with the corporate<br \/>\npower to own its properties and conduct its business as now conducted. The<br \/>\nCompany has the corporate power to execute, deliver and perform the Agreement,<br \/>\nincluding without limitation, the issuance and sale of the Shares. The Agreement<br \/>\nhas been duly authorized by all requisite corporate action, executed and<br \/>\ndelivered by the Company. The Agreement constitutes a valid and binding<br \/>\nagreement of the Company enforceable in accordance with its terms, subject to<br \/>\nthe following limitations, qualifications and exceptions: (a) the effect of<br \/>\nbankruptcy, insolvency, reorganization, moratorium, fraudulent transfer or<br \/>\nconveyance or similar laws relating to or affecting the rights of creditors,<br \/>\nincluding, without limitation, Section 548 of the federal Bankruptcy Code and<br \/>\nSection 547 of the federal Bankruptcy Code and comparable provisions of state<br \/>\nlaw; and (b) the effect of general principles of equity, including, without<br \/>\nlimitation, concepts of materiality, reasonableness, good faith and fair<br \/>\ndealing, the possible unavailability of specific performance or injunctive<br \/>\nrelief, regardless of whether considered in a proceeding in equity or at law,<br \/>\nand the exercise of judicial discretion in appropriate cases.<\/p>\n<p>        2.      The Shares, when issued in compliance with the provisions of the<br \/>\nAgreement, will be duly authorized and validly issued and fully paid and<br \/>\nnon-assessable.<\/p>\n<p>        3.      Based on the representations of the Investor in the Agreement,<br \/>\nthe offer and sale of the Shares pursuant to the terms of the Agreement are<br \/>\nexempt from the registration requirements of Section 5 of the Securities Act of<br \/>\n1933, as amended.<\/p>\n<p>        4.      The execution, delivery and performance of the Agreement and the<br \/>\nissuance and sale of the Shares in accordance with the Agreement will not<br \/>\nviolate or conflict with, or result in a breach of or default under, the<br \/>\nCertificate of Incorporation, as amended or By-laws, as amended of the Company.<\/p>\n<p>        5.      To our knowledge there is no action, suit, proceeding or<br \/>\ninvestigation pending against the Company before any court or governmental<br \/>\nagency (I) that questions the validity of the Agreement or the right of the<br \/>\nCompany to enter into the Agreement or (ii) that, if determined adversely, would<br \/>\nbe likely to result in a Material Adverse Effect on the financial condition or<br \/>\nbusiness of the Company.<\/p>\n<p>                This opinion is limited to the general corporate laws of the<br \/>\nState of Delaware (excluding municipal, county and local ordinances and<br \/>\nregulations) without reference to conflict <\/p>\n<p>                                       32<\/p>\n<p>of law principles, and the federal laws of the United States of America, and to<br \/>\npresent judicial interpretations thereof, and to facts as they presently exist,<br \/>\nand we express no opinion with respect to any other law or the law of any other<br \/>\njurisdiction. In rendering this opinion, we have no obligation to revise or<br \/>\nsupplement it should the current laws of the State of Delaware, or the federal<br \/>\nlaws of the United States of America be changed by legislative action, judicial<br \/>\ndecision or otherwise.<\/p>\n<p>        Further, the opinions contained in this letter are given as of the date<br \/>\nof this letter and are rendered exclusively for your benefit solely in<br \/>\nconnection with the consummation of the transactions contemplated by the<br \/>\nAgreement and may not be relied upon to state directly or indirectly any general<br \/>\nproposition or for any other purpose. We hereby disclaim any obligation to<br \/>\nnotify any person or entity after the date hereof if any change in fact or law<br \/>\nshould change our opinions with respect to any matter set forth in this letter.<\/p>\n<p>        This opinion may be relied upon by you only in connection with the<br \/>\ntransactions contemplated by the Agreement. No other use or distribution of this<br \/>\nopinion may be made, and no other person or party may rely on this opinion,<br \/>\nwithout our express prior written consent in each instance.<\/p>\n<p>                                                     Very truly yours,<\/p>\n<p>                                       33<\/p>\n<p>                                  SCHEDULE 5.7<\/p>\n<p>                               ALLIANCE AGREEMENT<\/p>\n<p>                                       34<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[8106,9124],"corporate_contracts_industries":[9508,9466],"corporate_contracts_types":[9622,9627],"class_list":["post-43717","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-macrovision-corp","corporate_contracts_companies-ttr-technologies-inc","corporate_contracts_industries-technology__hardware","corporate_contracts_industries-media__movies","corporate_contracts_types-planning","corporate_contracts_types-planning__purchase"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/43717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=43717"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=43717"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=43717"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=43717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}